GRAIL, Inc. Common Stock (GRAL)

• Market cap: $621M
• 1 day: -5.71%
• 5 days: 0.71%
• 1 month: -1.33%
• 3 months: 34.30%
• 6 months: 23.53%
• Year to date: 35.29%
• 1 year: 35.29%
• 5 years: 35.29%
• 10 years: 35.29%
• Sector: Healthcare
• Industry: Medical Laboratories

About: GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.

Employees: 1,170

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

2% more call options, than puts

Call options by funds: $3.32M | Put options by funds: $3.24M

2.29% less ownership

Funds ownership: 72.9% [Q2] → 70.6% (-2.29%) [Q3]

16% less funds holding

Funds holding: 359 [Q2] → 300 (-59) [Q3]

20% less capital invested

Capital invested by funds: $348M [Q2] → $280M (-$68.4M) [Q3]

25% less funds holding in top 10

Funds holding in top 10: 4 [Q2] → 3 (-1) [Q3]

40% less first-time investments, than exits

New positions opened: 90 | Existing positions closed: 149

53% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 109

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $16 13% downside
• Avg. target: $16 13% downside
• High target: $16 13% downside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

Morgan Stanley Tejas Savant 33% 1-year accuracy 4 / 12 met price target

13% downside $16

Equal-Weight Initiated

27 Nov 2024